DOI QR코드

DOI QR Code

Osseointegration of dental implant in the mandible with diffuse sclerosing osteomyelitis: Report of a rare case

미만성 경화성 골수염을 동반한 하악에서 임플란트의 골유착

  • Kang, Hyeon-Goo (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University) ;
  • Ko, Kyung-Ho (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University) ;
  • Huh, Yoon-Hyuk (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University) ;
  • Cho, Lee-Ra (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University) ;
  • Park, Chan-Jin (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University)
  • 강현구 (강릉원주대학교 치과대학 치과보철학교실 및 구강과학연구소) ;
  • 고경호 (강릉원주대학교 치과대학 치과보철학교실 및 구강과학연구소) ;
  • 허윤혁 (강릉원주대학교 치과대학 치과보철학교실 및 구강과학연구소) ;
  • 조리라 (강릉원주대학교 치과대학 치과보철학교실 및 구강과학연구소) ;
  • 박찬진 (강릉원주대학교 치과대학 치과보철학교실 및 구강과학연구소)
  • Received : 2020.12.08
  • Accepted : 2021.07.05
  • Published : 2021.07.31

Abstract

There are very few reports of the restoration of tooth loss using dental implants in patients with diffuse sclerosing osteomyelitis (DSO). Because the patients with DSO have unfavorable bone quality for osseointegration of dental implants, additional considerations such as surgical trauma, infection control, and an extended healing period are essential when placing dental implants. The purpose of this study is to report on the success of osseointegration of a dental implant in the patient with DSO.

미만성 경화성 골수염(diffuse sclerosing osteomyelitis, DSO) 환자에서 임플란트를 사용하여 손실된 치아의 회복에 대한 보고는 거의 없다. DSO 환자는 임플란트의 골유착에 불리한 골질을 지니고 있기 때문에 임플란트를 식립할 때, 외과적 외상, 감염 관리 및 연장된 치유 기간과 같은 추가적인 고려사항이 필수적이다. 본 증례는 DSO 환자에서 임플란트 골유착의 실패와 성공에 관한 보고이다.

Keywords

References

  1. Jacobsson S. Diffuse sclerosing ostemyelitis of the mandible. Acta Otolaryngol Suppl 1979;360:61-3.
  2. Neville B, Damm DD, Allen C, Bouquot J. Oral and maxillofacial pathology. 3rd Ed. Philadelphia; Saunders; 2008. p. 144-7.
  3. Montonen M, Kalso E, Pylkkaren L, Lindstrorm BM, Lindqvist C. Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible. Int J Oral Maxillofac Surg 2001;30:313-7. https://doi.org/10.1054/ijom.2001.0061
  4. Urade M, Noguchi K, Takaoka K, Moridera K, Kishimoto H. Diffuse sclerosing osteomyelitis of the mandible successfully treated with pamidronate: a long-term follow-up report. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:e9-12.
  5. Otto S, Burian E, Troeltzsch M, Kaeppler G, Ehrenfeld M. Denosumab as a potential treatment alternative for patients suffering from diffuse sclerosing osteomyelitis of the mandible-A rapid communication. J Craniomaxillofac Surg 2018;46:534-7. https://doi.org/10.1016/j.jcms.2017.10.011
  6. van Merkesteyn JP, Groot RH, Bras J, McCarroll RS, Bakker DJ. Diffuse sclerosing osteomyelitis of the mandible: a new concept of its etiology. Oral Surg Oral Med Oral Pathol 1990;70:414-9. https://doi.org/10.1016/0030-4220(90)90200-C
  7. Kniha K, Heussen N, Weber E, Mohlhenrich SC, Holzle F, Modabber A. Temperature threshold values of bone necrosis for thermo-explantation of dental implants-a systematic review on preclinical in vivo research. Materials (Basel) 2020;13:3461. https://doi.org/10.3390/ma13163461
  8. Kuijpers SC, de Jong E, Hamdy NA, van Merkesteyn JP. Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. J Craniomaxillofac Surg 2011;39:65-8. https://doi.org/10.1016/j.jcms.2010.03.014
  9. Shuren SL. The use of implant therapy in diffuse sclerosing osteomyelitis. J Oral Implantol 1994;20:60-2.